Austere Pharma facility at UK, started its commercial production from 2005. The plant is in accordance with the guidelines of various international regulatory bodies like US-FDA, TGA, MHRA, MCC, WHO, ANVISA etc, which is the true testimony of Austere Pharma Life Science Ltd’s commitment towards quality and safety. Such standards helped Austere to attain strong footholds in the global market.
Overview:
Austere Pharma Life Science Ltd believes that sustainable development, in any environment, has to be a participatory process, with employees and the local population, being the biggest stakeholder. Austere Pharma Life Science Ltdworks closely with the local community to keep the air, water and land safe and healthy.
Austere Pharma Life Science Ltd takes active interest in the well-being of its employees and the local community and continue to make a valuable difference.
Austere Pharma Life Science Ltd plays a proactive role in minimizing pollution in its units. Its SHE policy is mentored by an in-house SHE organizational set-up. In its journey towards sustainability, the SHE team works towards achieving its benchmarks every year.
Austere Pharma Life Science Ltd manufacturing facilities meet stringent cGMP norms, Revised Schedule M and WHO TRS 968. Our plant is also WHO-GMP certified which is the testimony to its compliance with the World Health Organization’s international norms.